Basic Information
Mymetics Corporation is a Switzerland-based biotechnology company with a research laboratory in the Netherlands, focusing on the development of next-generation vaccines for the prevention of infectious and debilitating diseases. The organization is currently developing several vaccines, including those for Covid-19, HIV-1/AIDS, and malaria. Mymetics' core technology and expertise lie in the use of virosomes, lipid carriers containing functional fusion viral proteins and natural membrane proteins, as well as rationally designed antigens.

